Decreasing effect sizes for effectiveness studies - Implications for the transport of evidence-based treatments: Comment on Curtis, Ronan, and Borduin (2004)
Decreasing effect sizes for effectiveness studies - Implications for the transport of evidence-based treatments: Comment on Curtis, Ronan, and Borduin (2004)
复制标题
DOI：
10.1037/0893-3200.18.3.420
复制
发表时间：
2004-09-01
影响因子：
2.7
通讯作者：
Henggeler, SW
中科院分区：
文献类型：
--
作者：
Henggeler, SW
N. M. Curtis， K. R. Ronan和C. M. Borduin（2004）对更广泛领域的荟萃分析的最重要发现可能是多系统治疗疗效与有效性研究之间效应大小的差异。这一差异对将循证治疗转移到社区实践环境的研究具有重要意义。例如，在疗效研究中很少考虑的因素（如资金结构、组织气候、项目成熟度、地点特征）正在成为治疗保真度的重要决定因素，进而影响现实世界中实践的临床结果。目前的研究清楚地表明，循证实践可以成功地传播，但关于这种传播的最佳参数仍有待学习。
The most important finding from the N. M. Curtis, K. R. Ronan, and C. M. Borduin (2004) meta-analysis for the broader field is likely the difference in effect sizes between multisystemic therapy efficacy versus effectiveness studies. This difference has important implications for research on the transport of evidence-based treatments to community practice settings. For example, factors rarely considered in efficacy research (e.g., funding structures, organizational climate, program maturity, site characteristics) are emerging as important determinants of treatment fidelity and, in turn, clinical outcomes for practice in real-world settings. Current research is clearly demonstrating that evidence-based practices can be successfully transported, but much remains to be learned regarding the optimal parameters of such transport.